Your weekly dose of interesting tidbits from around the pharma web… With the major Democratic 2020 candidates campaigning on lowering drug prices, march-in rights are now back in focus as a tool to achieve that goal. Biopharmas are...
Read More
Your weekly dose of interesting tidbits from around the pharma web… HHS’ Office of Civil Rights imposed a fine on the Texas Health and Human Services Commission $1.6 million. It also fined the Rochester Medical Center $3 million...
Your weekly dose of interesting tidbits from around the pharma web… Six of the seven traditional large pharmas beat Wall Street forecasts reporting stronger-than-expected sales for the third quarter. While Eli Lilly just barely missed Wall Street expectations,...
Your weekly dose of interesting tidbits from around the pharma web… Breast implant monitoring is important to patients, advocates, physicians and even manufacturers. That’s why Allergan is backing the Aesthetic Society creation of the Patient App. The HIPAA-compliant personalized...
Your weekly dose of interesting tidbits from around the pharma web… AI and big data join together to predict which research will influence future medical treatments. (Worldpharmanews) More generic drugs are being approved by the FDA but...
Your regular dose of interesting tidbits from around the pharma web… California Governor Gavin Newsome recently signed a bill, Assembly Bill 824, to outlaw the practice of pharma companies settling patent infringement lawsuits brought by generic manufacturers to...
English